Harbour Trust & Investment Management Co Has $261,000 Holdings in CVS Health Co. (NYSE:CVS)

Harbour Trust & Investment Management Co decreased its stake in shares of CVS Health Co. (NYSE:CVS) by 32.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,150 shares of the pharmacy operator’s stock after selling 1,971 shares during the quarter. Harbour Trust & Investment Management Co’s holdings in CVS Health were worth $261,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of CVS. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter valued at $31,000. First Community Trust NA grew its stake in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the period. Kathleen S. Wright Associates Inc. bought a new stake in CVS Health in the 3rd quarter valued at about $33,000. ORG Partners LLC boosted its holdings in CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 592 shares in the last quarter. Finally, Oliver Lagore Vanvalin Investment Group grew its stake in CVS Health by 71.0% in the second quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 247 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $56.11 on Friday. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The stock has a market cap of $70.44 billion, a P/E ratio of 9.86, a PEG ratio of 0.93 and a beta of 0.54. The business’s 50-day moving average price is $59.88 and its two-hundred day moving average price is $60.17.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.21 EPS. As a group, equities analysts predict that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.74%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s payout ratio is currently 46.75%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CVS. Evercore ISI upped their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Barclays reduced their price objective on shares of CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a report on Wednesday, September 4th. Finally, Wells Fargo & Company lifted their price target on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $74.58.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.